Paper169206
Adenosine 3',5'-monophosphate analogue increases the outflow facility of the primate eye.
Neufeld AH and 1 other. Invest Ophthalmol, 1975. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Adenosine 3',5'-monophosphate analogue increases the outflow facility of the primate eye. Papers, record 169206. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/169206
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adenosine 3',5'-monophosphate analogue increases the outflow facility of the primate eye.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aqueous Humor | Major topic |
| Cyclic AMP | Major topic |
| Animals | |
| Cercopithecus | |
| Haplorhini | |
| Secretory Rate |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27916026 | Role of cyclic AMP in the eye with glaucoma. | BMB Rep | 2017 | https://conductscience.org/library/papers/27916026 | PubMed |
| 24320087 | Control of outflow resistance by soluble adenylyl cyclase. | J Ocul Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24320087 | PubMed |
| 23951163 | cAMP level modulates scleral collagen remodeling, a critical step in the development of myopia. | PLoS One | 2013 | https://conductscience.org/library/papers/23951163 | PubMed |
| 21071747 | Effect of elevated intracellular cAMP levels on actomyosin contraction in bovine trabecular meshwork cells. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21071747 | PubMed |
| 18053986 | Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail. | Exp Eye Res | 2008 | https://conductscience.org/library/papers/18053986 | PubMed |
| 6309689 | A major pathway for the regulation of intraocular pressure. | Int Ophthalmol | 1983 | https://conductscience.org/library/papers/6309689 | PubMed |
| 6093393 | The adenylate cyclase receptor complex and aqueous humor formation. | Yale J Biol Med | 1984 | https://conductscience.org/library/papers/6093393 | PubMed |
| 1982749 | Epinephrine effects on major cell types of the aqueous outflow pathway: in vitro studies/clinical implications. | Trans Am Ophthalmol Soc | 1990 | https://conductscience.org/library/papers/1982749 | PubMed |
| 44821 | Effects of adrenergic drugs on aqueous cAMP and cGMP and intraocular pressure. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1979 | https://conductscience.org/library/papers/44821 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/169206
GET https://conductscience.org/api/papers/v1/169206/authors